The Journal of Urology
Volume 179, Issue 5 , Pages 1658-1659 , May 2008

Predicting Prostate Cancer Behavior—What is a Urologist to Do?

  • Michael W. Kattan

      Affiliations

    • Financial interest and/or other relationship with Sanofi-Aventis.

References 

  1. Meehl PE. Causes and effects of my disturbing little book. J Pers Assess. 1986;50:370
  2. Chatfield C. Model uncertainty, data mining and statistical inference. J R Stat Soc. 1995;158:419
  3. Kattan MW. Evaluating a new marker’s predictive contribution. Clin Cancer Res. 2004;10:822
  4. Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13:111
  5. Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol. 2005;173:421
  6. Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schroder FH. Prediction of indolent prostate cancer: validation and updating of a prognositic nomogram. J Urol. 2007;177:107

PII: S0022-5347(08)00330-3

doi: 10.1016/j.juro.2008.02.002

The Journal of Urology
Volume 179, Issue 5 , Pages 1658-1659 , May 2008

Article Tools